Literature DB >> 1648674

Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases.

M Steinfath1, B Geertz, W Schmitz, H Scholz, A Haverich, I Breil, P Hanrath, C Reupcke, M Sigmund, H B Lo.   

Abstract

Cardiac beta-adrenoceptor density and beta 1- and beta 2-subtype distribution were examined in human left ventricular myocardium from transplant donors serving as controls and from patients with mitral valve stenosis, aortic valve stenosis, idiopathic dilated cardiomyopathy, and ischaemic cardiomyopathy respectively. The total beta-adrenoceptor density was similar in transplant donors and patients with moderate heart failure (NYHA II-III) due to mitral valve stenosis, but was markedly reduced in all forms of severe heart failure (NYHA III-IV) studied. A reduction of both beta 1- and beta 2-adrenoceptors was found in patients with severe heart failure due to mitral valve stenosis or ischaemic cardiomyopathy. In contrast, a selective down-regulation of beta 1-adrenoceptors with unchanged beta 2-adrenoceptors and hence a relative increase in the latter was observed in idiopathic dilated cardiomyopathy and aortic valve stenosis. It is concluded that the extent of total beta-adrenoceptor down-regulation is related to the degree of heart failure. Selective loss of beta 1-adrenoceptors is not specific for idiopathic dilated cardiomyopathy but also occurs in aortic valve stenosis. Changes in beta 1- and beta 2-subtype distribution are rather related to the aetiology than to the clinical degree of heart failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648674     DOI: 10.1007/bf00168613

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Characterization of beta-1 and beta-2 adrenoceptors in guinea pig atrium: functional and receptor binding studies.

Authors:  P Molenaar; R J Summers
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

2.  CGP 20712 A: a useful tool for quantitating beta 1- and beta 2-adrenoceptors.

Authors:  D J Dooley; H Bittiger; N C Reymann
Journal:  Eur J Pharmacol       Date:  1986-10-14       Impact factor: 4.432

3.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

Review 4.  Beta-adrenergic function in heart muscle disease and heart failure.

Authors:  M R Bristow; N E Kantrowitz; R Ginsburg; M B Fowler
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

5.  Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.

Authors:  M Böhm; B Pieske; P Schnabel; R Schwinger; B Kemkes; W P Klövekorn; E Erdmann
Journal:  J Cardiovasc Pharmacol       Date:  1989-10       Impact factor: 3.105

Review 6.  Mitigation of beta 1- and/or beta 2-adrenoceptor function in human heart failure.

Authors:  M C Michel; A S Maisel; O E Brodde
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 7.  Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.

Authors:  M R Bristow; R E Hershberger; J D Port; E M Gilbert; A Sandoval; R Rasmussen; A E Cates; A M Feldman
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

8.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

9.  Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation.

Authors:  A J Kaumann; H Lemoine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

Review 10.  Neurohumoral mechanisms involved in congestive heart failure.

Authors:  G S Francis
Journal:  Am J Cardiol       Date:  1985-01-11       Impact factor: 2.778

View more
  20 in total

1.  Preclinical evaluation of an 18F-labelled beta1-adrenoceptor selective radioligand based on ICI 89,406.

Authors:  Marilyn P Law; Stefan Wagner; Klaus Kopka; Christiane Renner; Victor W Pike; Otmar Schober; Michael Schäfers
Journal:  Nucl Med Biol       Date:  2010-05       Impact factor: 2.408

2.  Down regulation of myocardial beta1-adrenoceptor signal transduction system in pacing-induced failure in dogs with aortic stenosis-induced left ventricular hypertrophy.

Authors:  J Tse; M W Huang; R J Leone; H R Weiss; Y Q He; P M Scholz
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

Review 3.  Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure.

Authors:  W Schmitz; P Boknik; B Linck; F U Müller
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

4.  Beta-adrenoceptors in the transplanted human heart: unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time.

Authors:  O E Brodde; M Khamssi; H R Zerkowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

5.  Hemodynamic correlates of baroreflex impairment of heart rate in experimental canine heart failure.

Authors:  M Brändle; W Wang; I H Zucker
Journal:  Basic Res Cardiol       Date:  1996 Mar-Apr       Impact factor: 17.165

Review 6.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

7.  Regional distribution of beta 1- and beta 2-adrenoceptors in the failing and nonfailing human heart.

Authors:  M Steinfath; J Lavicky; W Schmitz; H Scholz; V Döring; P Kalmár
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Down-regulated beta-adrenoceptors in severely failing human ventricles: uniform regional distribution, but no increased internalization.

Authors:  H F Pitschner; A Droege; M Mitze; M Schlepper; O E Brodde
Journal:  Basic Res Cardiol       Date:  1993 Mar-Apr       Impact factor: 17.165

9.  Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.

Authors:  George Suzuki; Takayuki Mishima; Elaine J Tanhehco; Victor G Sharov; Anastassia Todor; Sharad Rostogi; Ramesh C Gupta; Pervaiz A Chaudhry; Petros V Anagnostopoulos; Omar Nass; Sidney Goldstein; Hani N Sabbah
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 10.  Changes in adrenergic receptors during the development of heart failure.

Authors:  N S Dhalla; I M Dixon; S Suzuki; M Kaneko; A Kobayashi; R E Beamish
Journal:  Mol Cell Biochem       Date:  1992-09-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.